Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial-Reference-Cited by-同舟云学术

Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Published:2007-06 Issue:12 Volume:99 Page:S68-S79
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kingry Connie,Bastien Arnaud,Booth Gillian,Geraci Therese S.,Kirpach Brenda R.,Lovato Laura C.,Margolis Karen L.,Rosenberg Yves,Sperl-Hillen JoAnne M.,Vargo Laura,Williamson Jeff D.,Probstfield Jeffrey L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Recruitment in NHLBI population-based studies and clinical trials: data analysis and survey results;Probstfield;Control Clin Trials,1987

2. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension;Staessen;Lancet,1997

3. Screening and recruitment experience in the full scale SHEP trial;Petrovitch;Hypertension,1991

4. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT);Pressel;Control Clin Trials,2001

5. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial;Gerstein;Diabetologia,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France;Journal of Comparative Effectiveness Research;2024-03

2. Use of comprehensive recruitment strategies in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE) multi-center clinical trial;Clinical Trials;2023-06-17

3. Representation of Women in Contemporary Kidney Transplant Trials;Transplant International;2023-04-14

4. Association Between Long-Term Visit-to-Visit Hemoglobin A1c and Cardiovascular Risk in Type 2 Diabetes: The ACCORD Trial;Frontiers in Cardiovascular Medicine;2021-11-24

5. New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks;Journal of Evidence-Based Medicine;2021-11